The government will discuss a road map for the pharma and medical device sector for the next 25 years, including a policy on manufacturing patent drugs, in a meeting of the sector next week, chemicals and fertilizers minister Mansukh Mandaviya said on Friday.
He said the government will brainstorm with stakeholders at the 25-27 April India Pharmaceutical and Medical Devices Conference 2022. The event, themed “vision 2047: transformative roadmap for the future”, is set to be attended by pharma representatives from across the world.
“We have gained a benefit from the previous India pharma conference. Every year, this meeting is convened with focus issues such as building resilient supply chains and the need to harness technology in the pharma and medical device sectors, the potential to tap into the manufacturing of medical equipment, and many more. We have already seen India as the pharmacy of the world. For example, out of every five medicines used in the world, one is a generic medicine manufactured in India. There are more than 3,500 pharma companies and over 10,500 manufacturing plants. We have to go beyond this and we will brainstorm in this India Pharma conference,” Mandaviya said.
Apart from generic medicines, the Indian pharmaceuticals sector is also focusing on increasing patented drug manufacturing.
“For patent drug manufacturing, we need research, innovation and policy. In the coming days, we will brainstorm with the stakeholders on various fronts—policy, economic, research and innovation,” he added.
Bhagwanth Khuba, minister of state for chemicals and fertilizers stressed on India’s production of vaccines, therapeutics, PPE kits and diagnostic tests, medical oxygen, ventilators, etc. in record time during the pandemic crisis.
S. Aparna, secretary, department of pharmaceuticals highlighted the role of the government in supporting the medical devices industry.
The department has been working to ensure a stable long-term policy environment for both manufacturing and research and development, and reduce the compliance burden on the industry which is supported with the help of other ministries and central government departments.
Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess